Skip to main content
This block is broken or missing. You may be missing content or you might need to enable the original module.
Home

Main sub menu

  • Investors
  • Careers
    • Working at Recipharm
    • The Recipharm story
    • Meet our employees
    • Current vacancies
  • Contact
    • Contact us
    • Development services contacts
    • Manufacturing services contacts
    • Locations
      • France
        • Fontaine
        • Kaysersberg
        • Monts
        • Pessac
      • Germany
        • Wasserburg
      • India
        • Bengaluru
        • Karnal / Paonta Sahib
      • Israel
        • Ness Ziona
      • Italy
        • Brescia
        • Lainate
        • Masate
        • Paderno Dugnano
      • Portugal
        • Odivelas
        • Queluz
      • Spain
        • Parets
        • Leganés
      • Sweden
        • Höganäs
        • Stockholm city (HQ)
        • Karlskoga
        • Solna
        • Stockholm
        • Strängnäs
        • Uppsala
        • Uppsala Development
      • UK
        • Holmes Chapel
        • Ashton
      • USA
        • Research Triangle Park

Main navigation

  • Development
    • Drug substance
    • Drug product
    • Analytical chemistry
    • Clinical trial material (CTM)
  • Manufacturing
    • Solids
    • Semi-solids
    • Liquids
    • Inhalation
    • Injectables
    • Ophthalmics
  • Solutions
    • Recipharm Analytical Solutions™
    • Recipharm Inhalation Solutions™
    • Recipharm Pathway to Clinic®
    • Serialisation
  • Learn
  • Press & events
    • Press
    • Events
    • Reports
    • Insights
  • Our story
    • Recipharm in brief
    • Business model
    • Business overview
    • Sustainability
    • Company history

Press & events

What's happening?

Stay updated on our latest news and events.

Press and Event

  • Press
  • Events
  • Reports
  • Insights
Displaying 1 - 10 of 31

Subscribe

Press

Recipharm commences new supply contract and completes purchase of facility in Spain

2017.12.01 Read more

Press

Recipharm awarded for growth in France

2017.11.27 Read more

Press

Recipharm equips a further three facilities for US serialisation

2017.11.27 Read more

Press

Interim report January - September 2017

2017.11.09 Read more

Press

Recipharm to end operations in two facilities in Sweden

2017.11.09 Read more

Press

Invitation to presentation of Recipharm’s interim report for the third quarter 2017 on the 9th November

2017.11.06 Read more

Press

Recipharm equips Lisbon facility for US and European serialisation

2017.10.23 Read more

Press

Recipharm winner of TRACKTS Award 2017

2017.09.29 Read more

Press

Recipharm signs long-term manufacturing agreement with major new customer and acquires facility in Spain

2017.09.20 Read more

Press

Recipharm and Kancera collaborate to manufacture clinical trial supply

2017.09.14 Read more

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Next page Next ›
  • Last page Last »

Footer menu

  • Privacy policy
  • Cookies
  • Website terms
  • T&C of sale and delivery
© 2019 Recipharm AB (publ). All rights reserved Stormfors Digitalbyrå